Story Poster
Photo by Matthew Pena, TexAgs
Texas A&M Baseball

DUH! Outfielder Braden Montgomery named SEC's Player of the Week

April 1, 2024
6,617

He’s superhuman.

And it was a superhuman weekend.

On Monday, the Southeastern Conference named Texas A&M outfielder Braden Montgomery as its Player of the Week for his performance in the Aggies’ three-game sweep of Auburn at Blue Bell Park.

Montgomery jumped Olsen Field not once, not twice, not thrice... But FOUR times as Tiger pitching had no answer for the All-American.

On the weekend, Montgomery was 7-for-14 (.500) with four home runs, a double, two walks, eight runs scored and seven driven in.

One of his runs was perhaps the most important of the weekend, scoring on Ted Burton’s 12th-inning single to send Auburn back to the Plains winless.

In Thursday’s series opener, the switch-hitter set the tone for his entire weekend, crushing a two-run blast into Section 12.

A day later, he added two more: Another two-run bomb — this time an opposite-field shot off the left-field scoreboard — in the fifth before launching a towering solo homer to straightaway center field in the eighth.

Saving his best for last, Montgomery’s most majestic of the weekend came on Saturday — another two-run mash that traveled an impressive 457 feet over the camera tower in center field.

In a season of impressive weekends from No. 6, this might have been his best one yet.

On the year, Montgomery is hitting .381, and of his 40 hits, a whopping 16 have left the ballpark. He is slugging a ridiculous .933.

As one might expect, he’s all over the national leaderboards.

Montgomery’s 16 blasts rank second nationally, behind only Georgia’s Charlie Condon (19), but his 47 RBI paces the entire country.

Although this is his first SEC weekly honor, Montgomery is no stranger to accolades.

An already decorated player, his quest to add some Golden Spikes to his trophy case is well on its way.

 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.